Assenagon Asset Management S.A.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1546007
SENNINGERBERG, N4
Position in BMRN
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$100,826,560
-$7,671,410 QoQ
Shares Held
1,762,086
-8.3% QoQ
Ownership
0.910%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#17
of 561 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. BMRN ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in BMRN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,826,560 | 1,762,086 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $108,497,970 | 1,920,658 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $84,335,151 | 1,419,067 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $18,638,514 | 344,138 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $57,140,435 | 1,039,484 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $57,196,834 | 809,122 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $40,204,871 | 611,667 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $7,659,641 | 108,972 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $29,019,184 | 352,474 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $274,684 | 3,145 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,637,886 | 16,987 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $9,120,341 | 103,078 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $25,067,856 | 289,200 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $35,857,055 | 368,748 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $72,934,370 | 704,748 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $33,160,498 | 391,182 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $19,825,487 | 239,236 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,898,561 | 50,565 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $10,485,378 | 118,680 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,124,801 | 14,553 | Shares | Sole | 2021-10-19 | |
| 2020-09-30 | $541,004 | 7,111 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,587,179 | 20,976 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,198,970 | 14,189 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||